Literature DB >> 20089642

Structure function studies of vaccinia virus host range protein k1 reveal a novel functional surface for ankyrin repeat proteins.

Yongchao Li1, Xiangzhi Meng, Yan Xiang, Junpeng Deng.   

Abstract

Poxvirus host tropism at the cellular level is regulated by virus-encoded host range proteins acting downstream of virus entry. The functioning mechanisms of most host range proteins are unclear, but many contain multiple ankyrin (ANK) repeats, a motif that is known for ligand interaction through a concave surface. We report here the crystal structure of one of the ANK repeat-containing host range proteins, the vaccinia virus K1 protein. The structure, at a resolution of 2.3 A, showed that K1 consists entirely of ANK repeats, including seven complete ones and two incomplete ones, one each at the N and C terminus. Interestingly, Phe82 and Ser83, which were previously shown to be critical for K1's function, are solvent exposed and located on a convex surface, opposite the consensus ANK interaction surface. The importance of this convex surface was further supported by our additional mutagenesis studies. We found that K1's host range function was negatively affected by substitution of either Asn51 or Cys47 and completely abolished by substitution of both residues. Cys47 and Asn51 are also exposed on the convex surface, spatially adjacent to Phe82 and Ser83. Altogether, our data showed that K1 residues on a continuous convex ANK repeat surface are critical for the host range function, suggesting that K1 functions through ligand interaction and does so with a novel ANK interaction surface.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089642      PMCID: PMC2838116          DOI: 10.1128/JVI.02332-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Designed to be stable: crystal structure of a consensus ankyrin repeat protein.

Authors:  Andreas Kohl; H Kaspar Binz; Patrik Forrer; Michael T Stumpp; Andreas Plückthun; Markus G Grütter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

2.  Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2.

Authors:  Xiangzhi Meng; Yan Xiang
Journal:  Virology       Date:  2006-06-30       Impact factor: 3.616

3.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  The myxoma virus m-t5 ankyrin repeat host range protein is a novel adaptor that coordinately links the cellular signaling pathways mediated by Akt and Skp1 in virus-infected cells.

Authors:  Steven J Werden; Jerry Lanchbury; Donna Shattuck; Chris Neff; Max Dufford; Grant McFadden
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

5.  Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.

Authors:  Shu-Jung Chang; Jye-Chian Hsiao; Stephanie Sonnberg; Cheng-Ting Chiang; Min-Hsiang Yang; Der-Lii Tzou; Andrew A Mercer; Wen Chang
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex.

Authors:  Karin M Sperling; Astrid Schwantes; Barbara S Schnierle; Gerd Sutter
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

7.  The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Authors:  Karin M Sperling; Astrid Schwantes; Caroline Staib; Barbara S Schnierle; Gerd Sutter
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

8.  Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex.

Authors:  Nick van Buuren; Brianne Couturier; Yue Xiong; Michele Barry
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  High-affinity binders selected from designed ankyrin repeat protein libraries.

Authors:  H Kaspar Binz; Patrick Amstutz; Andreas Kohl; Michael T Stumpp; Christophe Briand; Patrik Forrer; Markus G Grütter; Andreas Plückthun
Journal:  Nat Biotechnol       Date:  2004-04-18       Impact factor: 54.908

10.  Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein.

Authors:  Brian Krumm; Xiangzhi Meng; Yongchao Li; Yan Xiang; Junpeng Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

View more
  15 in total

1.  Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.

Authors:  Kristen L Willis; Jeffrey O Langland; Joanna L Shisler
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

2.  Ankyrin-Like Protein AnkB Interacts with CatB, Affects Catalase Activity, and Enhances Resistance of Xanthomonas oryzae pv. oryzae and Xanthomonas oryzae pv. oryzicola to Phenazine-1-Carboxylic Acid.

Authors:  Xiayan Pan; Shu Xu; Jian Wu; Yabing Duan; Zhitian Zheng; Jianxin Wang; Xiushi Song; Mingguo Zhou
Journal:  Appl Environ Microbiol       Date:  2018-01-31       Impact factor: 4.792

3.  C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1.

Authors:  Xiangzhi Meng; John Schoggins; Lloyd Rose; Jingxin Cao; Alexander Ploss; Charles M Rice; Yan Xiang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.

Authors:  Camila Cristina Pasquali; Zeyaul Islam; Douglas Adamoski; Igor Monteze Ferreira; Ricardo Diogo Righeto; Jefferson Bettini; Rodrigo Villares Portugal; Wyatt Wai-Yin Yue; Ana Gonzalez; Sandra Martha Gomes Dias; Andre Luis Berteli Ambrosio
Journal:  J Biol Chem       Date:  2017-05-19       Impact factor: 5.157

6.  Formation of antiviral cytoplasmic granules during orthopoxvirus infection.

Authors:  M Simpson-Holley; N Kedersha; K Dower; K H Rubins; P Anderson; L E Hensley; J H Connor
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

7.  Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor with Unique Specificity for a Rodent SAMD9L.

Authors:  Fushun Zhang; Xiangzhi Meng; Michael B Townsend; Panayampalli Subbian Satheshkumar; Yan Xiang
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

8.  Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins.

Authors:  Xiangzhi Meng; Brian Krumm; Yongchao Li; Junpeng Deng; Yan Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

9.  A transcription blocker isolated from a designed repeat protein combinatorial library by in vivo functional screen.

Authors:  Elena B Tikhonova; Abdul S Ethayathulla; Yue Su; Parameswaran Hariharan; Shicong Xie; Lan Guan
Journal:  Sci Rep       Date:  2015-01-28       Impact factor: 4.379

10.  Deletion of C7L and K1L genes leads to significantly decreased virulence of recombinant vaccinia virus TianTan.

Authors:  Zheng Liu; Shuhui Wang; Qicheng Zhang; Meijuan Tian; Jue Hou; Rongmin Wang; Chang Liu; Xu Ji; Ying Liu; Yiming Shao
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.